SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lets Compare Valuations

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: thebeach who started this subject4/13/2001 4:22:38 PM
From: ms.smartest.person  Read Replies (1) of 6
 
Anyone know what stock on Michael Murphy's list this might be?

I received this from Investorplace.com today.

Act today to take advantage of an extraordinary one-day-only $500 discount on a charter subscription to Michael Murphy’s Biotech Investing! When you do, you’ll get immediate access to the name of a little-known company Murphy recently recommended…it has a prostate cancer drug under "priority review" by the FDA that overcomes many shortcomings of current prostate cancer drugs and could be a blockbuster in a huge ($2.5 billion!) market. The stock is below Murphy’s buy price now, but that will NOT last for long. Simply click here to take advantage of this extraordinary $500-off offer and learn all the details!

Obviously, I am not willing to put up the $1,795.00 to save $500. LOL

Merry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext